Loperamide

Generic name: Pronounced as (loe per' a mide)
Brand names
  • Imodium®
  • Imodium® AD
  • Imotil®
  • K-Pek II®
  • Kao-Paverin®
  • Kaopectate 1-D®
  • Maalox® Anti-Diarrheal
  • Pepto® Diarrhea Control
Click on drug name to hear pronunciation

Medical Content Reviewed By HelloPharmacist Staff

Last Revised - 04/15/2018

Loperamide may cause serious or life-threatening changes in your heart rhythm, especially in people who have taken more than the recommended amount. Tell your doctor if have or have ever had a prolonged QT interval (a rare heart problem that may cause irregular heartbeat, fainting, or sudden death), a slow or irregular heartbeat, or a low level of potassium in your blood. Also tell your doctor if you are taking or plan to take any of the following medications: amiodarone (Nexterone, Pacerone), chlorpromazine, haloperidol (Haldol), methadone (Dolophine, Methadose), moxifloxacin (Avelox), pentamidine (Nebupent, Pentam), procainamide, quinidine (in Nuedexta), sotalol (Betapace, Betapace AF), thioridazine, and ziprasidone (Geodon). Your doctor will probably tell you not to take loperamide if you are taking any of these medications or if you have any of these conditions. If you experience any of the following symptoms while taking loperamide, call your doctor immediately or instruct a friend or caregiver to call local emergency services at 911: fast, irregular, or pounding heartbeat; dizziness; lightheadedness; unresponsiveness; or fainting.

Taking more than the recommended amount of loperamide can cause heart problems that may be serious or cause death. Do not take a larger dose, take it more often, or take it for a longer period of time than prescribed by your doctor or as stated on the package.

Loperamide should not be given to a child younger than 2 years of age because of the risk of serious breathing and heart problems.

Nonprescription (over-the-counter) loperamide is used to control acute diarrhea (loose stools that come on suddenly and usually lasts less than 2 weeks), including travelers' diarrhea. Prescription loperamide is also used to control acute diarrhea and also ongoing diarrhea associated with inflammatory bowel disease (IBD; condition in which the lining of all or part of the intestine is swollen, irritated, or has sores). Prescription loperamide is also used to reduce the amount of fluid in people with ileostomies (surgery to create an opening for waste to leave the body through the abdomen). Loperamide is in a class of medications called antidiarrheal agents. It works by decreasing the flow of fluids and electrolytes into the bowel and by slowing down the movement of the bowel to decrease the number of bowel movements.

Loperamide comes as a tablet, capsule, and as a suspension or solution (liquid) to take by mouth. Nonprescription (over-the-counter) loperamide usually is taken immediately after each loose bowel movement but not more than the 24-hour maximum amount described on the label. Prescription loperamide is sometimes taken on a schedule (one or more times a day). Follow the directions on the package or on your prescription label carefully, and ask your doctor or pharmacist to explain any part you do not understand. Take loperamide exactly as directed.

If you are giving loperamide to your child, read the package label carefully to make sure that it is the right product for the age of the child. Loperamide should not be given to a child younger than 2 years of age. Check the package label to find out how much medication the child needs. If you know how much your child weighs, give the dose that matches that weight on the chart. If you don't know your child's weight, give the dose that matches your child's age. Ask your child's doctor if you don't know how much medication to give your child.

If you are taking loperamide liquid, do not use a household spoon to measure your dose. Use the measuring cup that came with the medication or use a spoon made especially for measuring liquid medication.

If you are taking loperamide for acute diarrhea and your symptoms get worse or if your diarrhea lasts longer than 48 hours, stop taking this medication and call your doctor.

This medication may be prescribed for other uses; ask your doctor or pharmacist for more information.

Before taking loperamide,

  • tell your doctor and pharmacist if you are allergic to loperamide, any other medications, or any of the ingredients in loperamide products. Check the package label for a list of the ingredients.

  • tell your doctor and pharmacist what other prescription and nonprescription medications, vitamins, nutritional supplements, and herbal products you are taking or plan to take. Be sure to mention any of the following: antibiotics such as clarithromycin (Biaxin, in PrevPac) and erythromycin (E.E.S., Ery-Tab, Eryc, others); certain antifungals such as itraconazole (Onmel, Sporanox) and ketoconazole; cimetidine (Tagamet), gemfibrozil (Lopid); quinine (Qualaquin), ranitidine (Zantac), ritonavir (Norvir, in Kaletra), or saquinavir (Invirase). Your doctor may need to change the doses of your medications or monitor you carefully for side effects.

  • tell your doctor if you have or have ever had ulcerative colitis (condition in which sores develop in the intestines causing pain and diarrhea). or colitis (swelling of the intestine caused by certain bacteria). Also, tell your doctor if you have a fever, blood or mucus in the stool, black stools, or stomach pain without diarrhea. Your doctor will probably tell you not to take loperamide or give it your child if you have one or more of these conditions.

  • tell your doctor if you have acquired immunodeficiency syndrome (AIDS) or if you have or have ever had liver disease.

  • tell your doctor and pharmacist if you are pregnant, plan to become pregnant, or are breastfeeding. If you become pregnant while taking loperamide, call your doctor.

  • you should know that this drug may make you drowsy and dizzy. Do not drive a car or operate machinery until you know how this drug affects you.

Drink plenty of water or other clear fluids to replace fluids lost while having diarrhea.

If you are taking scheduled doses of loperamide, take the missed dose as soon as you remember it. However, if it is almost time for the next dose, skip the missed dose and continue your regular dosing schedule. Do not take a double dose to make up for a missed one.

  • Loperamide may cause side effects. Tell your doctor if any of these symptoms are severe or do not go away:

    • constipation

    • fatigue

  • If you or someone taking loperamide experience any of the following symptoms, call your/their doctor immediately or get emergency medical treatment:

    • rash

    • red, peeling or blistering skin

    • hives

    • itching

    • wheezing

    • difficulty breathing

    • fever

    • stomach pain or swelling

    • bloody stools

  • If you experience a serious side effect, you or your doctor may send a report to the Food and Drug Administration's (FDA) MedWatch Adverse Event Reporting program online (http://www.fda.gov/Safety/MedWatch) or by phone (1-800-332-1088).

Keep this medication in the container it came in, tightly closed, and out of reach of children. Store it at room temperature and away from excess heat and moisture (not in the bathroom).

It is important to keep all medication out of sight and reach of children as many containers (such as weekly pill minders and those for eye drops, creams, patches, and inhalers) are not child-resistant and young children can open them easily. To protect young children from poisoning, always lock safety caps and immediately place the medication in a safe location – one that is up and away and out of their sight and reach. http://www.upandaway.org

Unneeded medications should be disposed of in special ways to ensure that pets, children, and other people cannot consume them. However, you should not flush this medication down the toilet. Instead, the best way to dispose of your medication is through a medicine take-back program. Talk to your pharmacist or contact your local garbage/recycling department to learn about take-back programs in your community. See the FDA's Safe Disposal of Medicines website (http://goo.gl/c4Rm4p) for more information if you do not have access to a take-back program.

In case of overdose, call the poison control helpline at 1-800-222-1222. Information is also available online at https://www.poisonhelp.org/help. If the victim has collapsed, had a seizure, has trouble breathing, or can't be awakened, immediately call emergency services at 911.

Symptoms of overdose may include the following:

  • nausea

  • inability to urinate

  • fainting

  • fast, pounding, or irregular heartbeat

  • unresponsiveness

  • confusion

  • narrowing of the pupils

  • slow and shallow breathing

  • shortness of breath

Ask your pharmacist any questions you have about taking this medicine.

It is important for you to keep a written list of all of the prescription and nonprescription (over-the-counter) medicines you are taking, as well as any products such as vitamins, minerals, or other dietary supplements. You should bring this list with you each time you visit a doctor or if you are admitted to a hospital. It is also important information to carry with you in case of emergencies.

  • Imodium® Multi-Symptom Relief (containing Loperamide, Simethicone)

Drug Interaction
Moxifloxacin Moxifloxacin The risk or severity of QTc prolongation can be increased when Moxifloxacin is combined with Loperamide.
Repaglinide Repaglinide The metabolism of Repaglinide can be decreased when combined with Loperamide.
Montelukast Montelukast The metabolism of Loperamide can be decreased when combined with Montelukast.
Insulin Glargine (rDNA origin) Injection Insulin Glargine (rDNA origin) Injection The risk or severity of hypoglycemia can be increased when Loperamide is combined with Insulin glargine.
Delavirdine Delavirdine The metabolism of Loperamide can be decreased when combined with Delavirdine.
Nevirapine Nevirapine The metabolism of Loperamide can be increased when combined with Nevirapine.
Atorvastatin Atorvastatin The metabolism of Atorvastatin can be decreased when combined with Loperamide.
Dolasetron Dolasetron The risk or severity of QTc prolongation can be increased when Dolasetron is combined with Loperamide.
Aminophylline Aminophylline The metabolism of Aminophylline can be decreased when combined with Loperamide.
Anagrelide Anagrelide The risk or severity of QTc prolongation can be increased when Loperamide is combined with Anagrelide.
Bisacodyl Bisacodyl The therapeutic efficacy of Bisacodyl can be decreased when used in combination with Loperamide.
Candesartan Candesartan The metabolism of Loperamide can be decreased when combined with Candesartan.
Cilostazol Cilostazol The metabolism of Cilostazol can be decreased when combined with Loperamide.
Clopidogrel Clopidogrel The therapeutic efficacy of Clopidogrel can be decreased when used in combination with Loperamide.
Erythromycin and Sulfisoxazole Erythromycin and Sulfisoxazole The serum concentration of Loperamide can be increased when it is combined with Erythromycin.
Fenofibrate Fenofibrate The metabolism of Fenofibrate can be decreased when combined with Loperamide.
Guanfacine Guanfacine The metabolism of Guanfacine can be decreased when combined with Loperamide.
Magnesium Gluconate Magnesium Gluconate The risk or severity of hypotension can be increased when Loperamide is combined with Magnesium gluconate.
Magnesium Hydroxide Magnesium Hydroxide The risk or severity of hypotension can be increased when Loperamide is combined with Magnesium hydroxide.
Magnesium Oxide Magnesium Oxide The risk or severity of hypotension can be increased when Loperamide is combined with Magnesium oxide.
Miglitol Miglitol The risk or severity of hypoglycemia can be increased when Loperamide is combined with Miglitol.
Olsalazine Olsalazine The risk or severity of hyperkalemia can be increased when Loperamide is combined with Olsalazine.
Paregoric Paregoric The serum concentration of Loperamide can be increased when it is combined with Morphine.
Penbutolol Penbutolol The risk or severity of bradycardia can be increased when Loperamide is combined with Acebutolol.
Polyethylene glycol-electrolyte solution (PEG-ES) Polyethylene glycol-electrolyte solution (PEG-ES) The therapeutic efficacy of Polyethylene glycol can be decreased when used in combination with Loperamide.
Potassium Potassium Potassium may increase the hyperkalemic activities of Loperamide.
Prednisone Prednisone The metabolism of Loperamide can be decreased when combined with Prednisone.
Psyllium Psyllium The therapeutic efficacy of Plantago seed can be decreased when used in combination with Loperamide.
Ranitidine Ranitidine The metabolism of Loperamide can be decreased when combined with Ranitidine.
Reserpine Reserpine The serum concentration of Loperamide can be increased when it is combined with Reserpine.
Tacrolimus Tacrolimus The serum concentration of Tacrolimus can be increased when it is combined with Loperamide.
Tizanidine Tizanidine The risk or severity of QTc prolongation can be increased when Tizanidine is combined with Loperamide.
Triamcinolone Triamcinolone The metabolism of Triamcinolone can be decreased when combined with Loperamide.
Famotidine Injection Famotidine Injection The risk or severity of QTc prolongation can be increased when Famotidine is combined with Loperamide.
Fluconazole Injection Fluconazole Injection The serum concentration of Loperamide can be increased when it is combined with Fluconazole.
Foscarnet Injection Foscarnet Injection The risk or severity of QTc prolongation can be increased when Foscarnet is combined with Loperamide.
Levofloxacin Injection Levofloxacin Injection The risk or severity of QTc prolongation can be increased when Loperamide is combined with Levofloxacin.
Meperidine Injection Meperidine Injection The metabolism of Meperidine can be decreased when combined with Loperamide.
Methylprednisolone Injection Methylprednisolone Injection The metabolism of Methylprednisolone can be decreased when combined with Loperamide.
Metoclopramide Injection Metoclopramide Injection The metabolism of Loperamide can be decreased when combined with Metoclopramide.
Metronidazole Injection Metronidazole Injection The metabolism of Loperamide can be decreased when combined with Metronidazole.
Morphine Injection Morphine Injection The serum concentration of Loperamide can be increased when it is combined with Morphine.
Zidovudine Injection Zidovudine Injection The metabolism of Loperamide can be decreased when combined with Zidovudine.
Altretamine Altretamine The metabolism of Loperamide can be decreased when combined with Amphetamine.
Cyclosporine Cyclosporine The metabolism of Cyclosporine can be decreased when combined with Loperamide.
Ondansetron Ondansetron The risk or severity of QTc prolongation can be increased when Loperamide is combined with Ondansetron.
Enoxaparin Injection Enoxaparin Injection The risk or severity of hyperkalemia can be increased when Loperamide is combined with Enoxaparin.
Granisetron Granisetron The risk or severity of QTc prolongation can be increased when Loperamide is combined with Granisetron.
Torsemide Torsemide The metabolism of Loperamide can be decreased when combined with Torasemide.
Olanzapine Olanzapine The risk or severity of QTc prolongation can be increased when Olanzapine is combined with Loperamide.
Dofetilide Dofetilide Loperamide may increase the arrhythmogenic activities of Dofetilide.
Entacapone Entacapone The metabolism of Loperamide can be decreased when combined with Entacapone.
Eprosartan Eprosartan The risk or severity of hyperkalemia can be increased when Loperamide is combined with Eprosartan.
Hydroxychloroquine Hydroxychloroquine The metabolism of Loperamide can be decreased when combined with Hydroxychloroquine.
Meloxicam Meloxicam The risk or severity of hyperkalemia can be increased when Meloxicam is combined with Loperamide.
Telmisartan Telmisartan The risk or severity of hyperkalemia can be increased when Loperamide is combined with Telmisartan.
Anakinra Anakinra The metabolism of Loperamide can be increased when combined with Anakinra.
Desloratadine Desloratadine The risk or severity of QTc prolongation can be increased when Loperamide is combined with Desloratadine.
Rivastigmine Rivastigmine Loperamide may increase the bradycardic activities of Rivastigmine.
Trimipramine Trimipramine The metabolism of Loperamide can be decreased when combined with Trimipramine.
Etanercept Injection Etanercept Injection The metabolism of Loperamide can be increased when combined with Etanercept.
Modafinil Modafinil The metabolism of Loperamide can be decreased when combined with Modafinil.
Perindopril Perindopril The risk or severity of hyperkalemia can be increased when Perindopril is combined with Loperamide.
Tenofovir Tenofovir The metabolism of Tenofovir can be decreased when combined with Loperamide.
Choline Magnesium Trisalicylate Choline Magnesium Trisalicylate The risk or severity of hyperkalemia can be increased when Loperamide is combined with Choline magnesium trisalicylate.
Sirolimus Sirolimus Loperamide may increase the immunosuppressive activities of Sirolimus.
Eplerenone Eplerenone The metabolism of Eplerenone can be decreased when combined with Loperamide.
Escitalopram Escitalopram The serum concentration of Escitalopram can be increased when it is combined with Loperamide.
Olmesartan Olmesartan The risk or severity of hyperkalemia can be increased when Olmesartan is combined with Loperamide.
Zonisamide Zonisamide Zonisamide may increase the arrhythmogenic activities of Loperamide.
Adalimumab Injection Adalimumab Injection The metabolism of Loperamide can be increased when combined with Adalimumab.
Aripiprazole Aripiprazole The metabolism of Aripiprazole can be decreased when combined with Loperamide.
Atomoxetine Atomoxetine The risk or severity of QTc prolongation can be increased when Atomoxetine is combined with Loperamide.
Atazanavir Atazanavir The metabolism of Atazanavir can be decreased when combined with Loperamide.
Almotriptan Almotriptan The metabolism of Almotriptan can be decreased when combined with Loperamide.
Eletriptan Eletriptan The metabolism of Loperamide can be decreased when combined with Eletriptan.
Mefloquine Mefloquine The risk or severity of QTc prolongation can be increased when Mefloquine is combined with Loperamide.
Polyethylene Glycol 3350 Polyethylene Glycol 3350 The therapeutic efficacy of Polyethylene glycol can be decreased when used in combination with Loperamide.
Rosuvastatin Rosuvastatin The metabolism of Rosuvastatin can be decreased when combined with Loperamide.
Vardenafil Vardenafil The metabolism of Vardenafil can be decreased when combined with Loperamide.
Alfuzosin Alfuzosin The metabolism of Alfuzosin can be decreased when combined with Loperamide.
Memantine Memantine The metabolism of Loperamide can be decreased when combined with Memantine.
Tegaserod Tegaserod The metabolism of Tegaserod can be decreased when combined with Loperamide.
Tadalafil Tadalafil The serum concentration of Tadalafil can be increased when it is combined with Loperamide.
Gemifloxacin Gemifloxacin The risk or severity of QTc prolongation can be increased when Loperamide is combined with Gemifloxacin.
Progesterone Progesterone The metabolism of Loperamide can be decreased when combined with Progesterone.
Apomorphine Injection Apomorphine Injection The risk or severity of QTc prolongation can be increased when Apomorphine is combined with Loperamide.
Infliximab Injection Infliximab Injection The metabolism of Loperamide can be increased when combined with Infliximab.
Protriptyline Protriptyline The risk or severity of QTc prolongation can be increased when Protriptyline is combined with Loperamide.
Rifaximin Rifaximin The metabolism of Loperamide can be increased when combined with Rifaximin.
Duloxetine Duloxetine The metabolism of Duloxetine can be decreased when combined with Loperamide.
Norethindrone Norethindrone The metabolism of Norethisterone can be decreased when combined with Loperamide.
Trospium Trospium The metabolism of Loperamide can be decreased when combined with Trospium.
Cinacalcet Cinacalcet The metabolism of Loperamide can be decreased when combined with Cinacalcet.
Erlotinib Erlotinib The metabolism of Loperamide can be decreased when combined with Erlotinib.
Eszopiclone Eszopiclone The serum concentration of Eszopiclone can be increased when it is combined with Loperamide.
Insulin Aspart (rDNA Origin) Injection Insulin Aspart (rDNA Origin) Injection The risk or severity of hypoglycemia can be increased when Loperamide is combined with Insulin aspart.
Solifenacin Solifenacin The risk or severity of QTc prolongation can be increased when Solifenacin is combined with Loperamide.
Voriconazole Voriconazole The metabolism of Loperamide can be decreased when combined with Voriconazole.
Dextroamphetamine Dextroamphetamine The metabolism of Loperamide can be decreased when combined with Amphetamine.
Peginterferon Alfa-2b (PEG-Intron) Peginterferon Alfa-2b (PEG-Intron) The metabolism of Loperamide can be decreased when combined with Peginterferon alfa-2b.
Pramlintide Injection Pramlintide Injection The risk or severity of hypoglycemia can be increased when Loperamide is combined with Pramlintide.
Exenatide Injection Exenatide Injection The risk or severity of hypoglycemia can be increased when Loperamide is combined with Exenatide.
Ibandronate Ibandronate The risk or severity of QTc prolongation can be increased when Ibandronate is combined with Loperamide.
Darifenacin Darifenacin The metabolism of Darifenacin can be decreased when combined with Loperamide.
Fentanyl Fentanyl The metabolism of Fentanyl can be decreased when combined with Loperamide.
Pregabalin Pregabalin Pregabalin may increase the arrhythmogenic activities of Loperamide.
Deferasirox Deferasirox The metabolism of Loperamide can be decreased when combined with Deferasirox.
Phenylephrine Phenylephrine The risk or severity of hypertension can be decreased when Loperamide is combined with Phenylephrine.
Tipranavir Tipranavir The metabolism of Tipranavir can be decreased when combined with Loperamide.
Felbamate Felbamate The risk or severity of QTc prolongation can be increased when Felbamate is combined with Loperamide.
Insulin Detemir (rDNA Origin) Injection Insulin Detemir (rDNA Origin) Injection The risk or severity of hypoglycemia can be increased when Loperamide is combined with Insulin detemir.
Ranolazine Ranolazine The metabolism of Loperamide can be decreased when combined with Ranolazine.
Abatacept Injection Abatacept Injection The metabolism of Loperamide can be increased when combined with Abatacept.
Imatinib Imatinib The risk or severity of QTc prolongation can be increased when Imatinib is combined with Loperamide.
Sitagliptin Sitagliptin The serum concentration of Sitagliptin can be increased when it is combined with Loperamide.
Gefitinib Gefitinib The metabolism of Loperamide can be decreased when combined with Gefitinib.
Albuterol Albuterol The risk or severity of QTc prolongation can be increased when Salbutamol is combined with Loperamide.
Paliperidone Paliperidone The risk or severity of QTc prolongation can be increased when Loperamide is combined with Paliperidone.
Bortezomib Bortezomib The metabolism of Loperamide can be decreased when combined with Bortezomib.
Insulin Glulisine (rDNA origin) Injection Insulin Glulisine (rDNA origin) Injection The risk or severity of hypoglycemia can be increased when Loperamide is combined with Insulin glulisine.
Lubiprostone Lubiprostone The therapeutic efficacy of Lubiprostone can be decreased when used in combination with Loperamide.
Oxaliplatin Injection Oxaliplatin Injection The risk or severity of QTc prolongation can be increased when Oxaliplatin is combined with Loperamide.
Posaconazole Posaconazole The serum concentration of Posaconazole can be increased when it is combined with Loperamide.
Primaquine Primaquine The metabolism of Primaquine can be decreased when combined with Loperamide.
Aliskiren Aliskiren The risk or severity of hyperkalemia can be increased when Loperamide is combined with Aliskiren.
Darunavir Darunavir The serum concentration of Darunavir can be increased when it is combined with Loperamide.
Dimenhydrinate Dimenhydrinate The risk or severity of QTc prolongation can be increased when Loperamide is combined with Dimenhydrinate.
Lisdexamfetamine Lisdexamfetamine The metabolism of Loperamide can be decreased when combined with Lisdexamfetamine.
Nabilone Nabilone The metabolism of Loperamide can be decreased when combined with Nabilone.
Retapamulin Retapamulin The metabolism of Retapamulin can be decreased when combined with Loperamide.
Vorinostat Vorinostat The risk or severity of QTc prolongation can be increased when Vorinostat is combined with Loperamide.
Sorafenib Sorafenib The metabolism of Loperamide can be decreased when combined with Sorafenib.
Sunitinib Sunitinib The metabolism of Sunitinib can be decreased when combined with Loperamide.
Lapatinib Lapatinib The metabolism of Lapatinib can be decreased when combined with Loperamide.
Levocetirizine Levocetirizine The risk or severity of QTc prolongation can be increased when Levocetirizine is combined with Loperamide.
Dasatinib Dasatinib The metabolism of Dasatinib can be decreased when combined with Loperamide.
Mexiletine Mexiletine Mexiletine may increase the arrhythmogenic activities of Loperamide.
Armodafinil Armodafinil The metabolism of Loperamide can be increased when combined with Armodafinil.
Paclitaxel (with polyoxyethylated castor oil) Injection Paclitaxel (with polyoxyethylated castor oil) Injection The therapeutic efficacy of Castor oil can be decreased when used in combination with Loperamide.
Temsirolimus Temsirolimus The metabolism of Loperamide can be decreased when combined with Temsirolimus.
Maraviroc Maraviroc The metabolism of Maraviroc can be decreased when combined with Loperamide.
Nilotinib Nilotinib The metabolism of Nilotinib can be decreased when combined with Loperamide.
Toremifene Toremifene The risk or severity of QTc prolongation can be increased when Loperamide is combined with Toremifene.
Bexarotene Bexarotene The metabolism of Loperamide can be decreased when combined with Bexarotene.
Budesonide Budesonide The metabolism of Budesonide can be decreased when combined with Loperamide.
Arsenic Trioxide Injection Arsenic Trioxide Injection The risk or severity of QTc prolongation can be increased when Loperamide is combined with Arsenic trioxide.
Desvenlafaxine Desvenlafaxine The metabolism of Loperamide can be decreased when combined with Desvenlafaxine.
Cevimeline Cevimeline The metabolism of Loperamide can be decreased when combined with Cevimeline.
Nebivolol Nebivolol The risk or severity of bradycardia can be increased when Loperamide is combined with Nebivolol.
Tretinoin Tretinoin The metabolism of Loperamide can be decreased when combined with Tretinoin.
Bendamustine Injection Bendamustine Injection The serum concentration of Bendamustine can be increased when it is combined with Loperamide.
Flecainide Flecainide Loperamide may increase the arrhythmogenic activities of Flecainide.
Certolizumab Injection Certolizumab Injection The metabolism of Loperamide can be increased when combined with Certolizumab pegol.
Ixabepilone Injection Ixabepilone Injection The metabolism of Ixabepilone can be decreased when combined with Loperamide.
Irinotecan Injection Irinotecan Injection The serum concentration of SN-38, an active metabolite of Irinotecan, can be increased when used in combination with Loperamide.
Rufinamide Rufinamide The metabolism of Rufinamide can be decreased when combined with Loperamide.
Silodosin Silodosin The serum concentration of Silodosin can be increased when it is combined with Loperamide.
Midazolam Midazolam The serum concentration of Midazolam can be increased when it is combined with Loperamide.
Eltrombopag Eltrombopag The metabolism of Loperamide can be decreased when combined with Eltrombopag.
Milnacipran Milnacipran The metabolism of Milnacipran can be decreased when combined with Loperamide.
Sodium Phosphate Sodium Phosphate Loperamide may increase the hyperkalemic activities of Sodium phosphate, monobasic.
Fesoterodine Fesoterodine The metabolism of Fesoterodine can be decreased when combined with Loperamide.
Degarelix Injection Degarelix Injection The risk or severity of QTc prolongation can be increased when Degarelix is combined with Loperamide.
Betaxolol Betaxolol The risk or severity of bradycardia can be increased when Betaxolol is combined with Loperamide.
Iloperidone Iloperidone The metabolism of Iloperidone can be decreased when combined with Loperamide.
Prasugrel Prasugrel The metabolism of Prasugrel can be decreased when combined with Loperamide.
Lacosamide Lacosamide The metabolism of Lacosamide can be decreased when combined with Loperamide.
Everolimus Everolimus The metabolism of Loperamide can be decreased when combined with Everolimus.
Tolvaptan (low blood sodium) Tolvaptan (low blood sodium) The metabolism of Tolvaptan can be decreased when combined with Loperamide.
Dronedarone Dronedarone The metabolism of Dronedarone can be decreased when combined with Loperamide.
Palonosetron Injection Palonosetron Injection The metabolism of Loperamide can be decreased when combined with Palonosetron.
Saxagliptin Saxagliptin The metabolism of Saxagliptin can be decreased when combined with Loperamide.
Telavancin Injection Telavancin Injection The risk or severity of QTc prolongation can be increased when Loperamide is combined with Telavancin.
Romidepsin Injection Romidepsin Injection The metabolism of Romidepsin can be decreased when combined with Loperamide.
Tapentadol Tapentadol The metabolism of Loperamide can be decreased when combined with Tapentadol.
Topotecan Topotecan The serum concentration of Topotecan can be increased when it is combined with Loperamide.
Golimumab Injection Golimumab Injection The metabolism of Loperamide can be increased when combined with Golimumab.
Pazopanib Pazopanib The metabolism of Pazopanib can be decreased when combined with Loperamide.
Asenapine Asenapine The risk or severity of QTc prolongation can be increased when Loperamide is combined with Asenapine.
Pitavastatin Pitavastatin The metabolism of Pitavastatin can be decreased when combined with Loperamide.
Albendazole Albendazole The metabolism of Albendazole can be decreased when combined with Loperamide.
Oxymorphone Oxymorphone The metabolism of Oxymorphone can be decreased when combined with Loperamide.
Liraglutide Injection Liraglutide Injection The risk or severity of hypoglycemia can be increased when Loperamide is combined with Liraglutide.
Tocilizumab Injection Tocilizumab Injection The metabolism of Loperamide can be increased when combined with Tocilizumab.
Fingolimod Fingolimod Loperamide may increase the bradycardic activities of Fingolimod.
Eribulin Injection Eribulin Injection The risk or severity of QTc prolongation can be increased when Eribulin is combined with Loperamide.
Cabazitaxel Injection Cabazitaxel Injection The metabolism of Cabazitaxel can be decreased when combined with Loperamide.
Lurasidone Lurasidone The risk or severity of QTc prolongation can be increased when Lurasidone is combined with Loperamide.
Acetaminophen Injection Acetaminophen Injection The metabolism of Loperamide can be decreased when combined with Acetaminophen.
Vilazodone Vilazodone The metabolism of Vilazodone can be decreased when combined with Loperamide.
Terbutaline Injection Terbutaline Injection The risk or severity of QTc prolongation can be increased when Terbutaline is combined with Loperamide.
Azilsartan Azilsartan The risk or severity of hyperkalemia can be increased when Loperamide is combined with Azilsartan medoxomil.
Busulfan Injection Busulfan Injection The metabolism of Busulfan can be decreased when combined with Loperamide.
Roflumilast Roflumilast The metabolism of Roflumilast can be decreased when combined with Loperamide.
Linagliptin Linagliptin The metabolism of Linagliptin can be decreased when combined with Loperamide.
Rilpivirine Rilpivirine The metabolism of Loperamide can be decreased when combined with Rilpivirine.
Telaprevir Telaprevir The serum concentration of Glecaprevir can be increased when it is combined with Loperamide.
Potassium Iodide Potassium Iodide Potassium Iodide may increase the hyperkalemic activities of Loperamide.
Cyclophosphamide Injection Cyclophosphamide Injection The metabolism of Loperamide can be decreased when combined with Cyclophosphamide.
Abiraterone Abiraterone The metabolism of Abiraterone can be decreased when combined with Loperamide.
Triptorelin Injection Triptorelin Injection The risk or severity of QTc prolongation can be increased when Triptorelin is combined with Loperamide.
Rivaroxaban Rivaroxaban The serum concentration of Rivaroxaban can be increased when it is combined with Loperamide.
Ticagrelor Ticagrelor The serum concentration of Loperamide can be increased when it is combined with Ticagrelor.
Brentuximab Vedotin Injection Brentuximab Vedotin Injection The metabolism of Brentuximab vedotin can be decreased when combined with Loperamide.
Ruxolitinib Ruxolitinib The metabolism of Ruxolitinib can be decreased when combined with Loperamide.
Vandetanib Vandetanib The metabolism of Vandetanib can be decreased when combined with Loperamide.
Clobazam Clobazam The metabolism of Clobazam can be decreased when combined with Loperamide.
Vemurafenib Vemurafenib The serum concentration of Loperamide can be increased when it is combined with Vemurafenib.
Vismodegib Vismodegib The metabolism of Loperamide can be decreased when combined with Vismodegib.
Ivacaftor Ivacaftor The metabolism of Ivacaftor can be decreased when combined with Loperamide.
Axitinib Axitinib The metabolism of Axitinib can be decreased when combined with Loperamide.
Crizotinib Crizotinib The metabolism of Crizotinib can be decreased when combined with Loperamide.
Cabergoline Cabergoline The metabolism of Cabergoline can be decreased when combined with Loperamide.
Ambrisentan Ambrisentan The serum concentration of Ambrisentan can be increased when it is combined with Loperamide.
Carfilzomib Injection Carfilzomib Injection The serum concentration of Carfilzomib can be increased when it is combined with Loperamide.
Enzalutamide Enzalutamide The serum concentration of Loperamide can be increased when it is combined with Enzalutamide.
Mirabegron Mirabegron The metabolism of Mirabegron can be decreased when combined with Loperamide.
Regorafenib Regorafenib The metabolism of Regorafenib can be decreased when combined with Loperamide.
Bosutinib Bosutinib The metabolism of Loperamide can be decreased when combined with Bosutinib.
Corticotropin, Repository Injection Corticotropin, Repository Injection The metabolism of Corticotropin can be decreased when combined with Loperamide.
Linaclotide Linaclotide The therapeutic efficacy of Linaclotide can be decreased when used in combination with Loperamide.
Teriflunomide Teriflunomide The metabolism of Loperamide can be decreased when combined with Teriflunomide.
Lorcaserin Lorcaserin The risk or severity of hypoglycemia can be increased when Loperamide is combined with Mecasermin.
Cabozantinib (thyroid cancer) Cabozantinib (thyroid cancer) The metabolism of Cabozantinib can be decreased when combined with Loperamide.
Bedaquiline Bedaquiline The metabolism of Bedaquiline can be decreased when combined with Loperamide.
Tofacitinib Tofacitinib The metabolism of Tofacitinib can be decreased when combined with Loperamide.
Alogliptin Alogliptin The risk or severity of hypoglycemia can be increased when Loperamide is combined with Alogliptin.
Ponatinib Ponatinib The metabolism of Ponatinib can be decreased when combined with Loperamide.
Pomalidomide Pomalidomide The metabolism of Pomalidomide can be decreased when combined with Loperamide.
Ado-trastuzumab Emtansine Injection Ado-trastuzumab Emtansine Injection The metabolism of Trastuzumab emtansine can be decreased when combined with Loperamide.
Apixaban Apixaban The serum concentration of Apixaban can be increased when it is combined with Loperamide.
Canagliflozin Canagliflozin The serum concentration of Canagliflozin can be increased when it is combined with Loperamide.
Dabrafenib Dabrafenib The metabolism of Loperamide can be decreased when combined with Dabrafenib.
Ospemifene Ospemifene The metabolism of Ospemifene can be decreased when combined with Loperamide.
Trametinib Trametinib The metabolism of Loperamide can be decreased when combined with Trametinib.
Dolutegravir Dolutegravir The serum concentration of Dolutegravir can be increased when it is combined with Loperamide.
Afatinib Afatinib The serum concentration of Loperamide can be increased when it is combined with Afatinib.
Levomilnacipran Levomilnacipran The metabolism of Levomilnacipran can be decreased when combined with Loperamide.
Vortioxetine Vortioxetine The metabolism of Vortioxetine can be decreased when combined with Loperamide.
Perampanel Perampanel The metabolism of Perampanel can be decreased when combined with Loperamide.
Ibrutinib Ibrutinib The metabolism of Ibrutinib can be decreased when combined with Loperamide.
Lomitapide Lomitapide The metabolism of Loperamide can be decreased when combined with Lomitapide.
Ketorolac Injection Ketorolac Injection The metabolism of Loperamide can be decreased when combined with Ketorolac.
Simeprevir Simeprevir The serum concentration of Simeprevir can be increased when it is combined with Loperamide.
Sofosbuvir Sofosbuvir The serum concentration of Sofosbuvir can be increased when it is combined with Loperamide.
Dapagliflozin Dapagliflozin The risk or severity of hypoglycemia can be increased when Loperamide is combined with Dapagliflozin.
Apremilast Apremilast The metabolism of Loperamide can be increased when combined with Apremilast.
Ceritinib Ceritinib Loperamide may increase the bradycardic activities of Ceritinib.
Siltuximab Injection Siltuximab Injection The metabolism of Loperamide can be increased when combined with Siltuximab.
Albiglutide Injection Albiglutide Injection The risk or severity of hypoglycemia can be increased when Loperamide is combined with Albiglutide.
Belinostat Injection Belinostat Injection The serum concentration of Belinostat can be increased when it is combined with Loperamide.
Idelalisib Idelalisib The metabolism of Idelalisib can be decreased when combined with Loperamide.
Oritavancin Injection Oritavancin Injection The metabolism of Loperamide can be decreased when combined with Oritavancin.
Empagliflozin Empagliflozin The risk or severity of hypoglycemia can be increased when Loperamide is combined with Empagliflozin.
Vorapaxar Vorapaxar The metabolism of Vorapaxar can be decreased when combined with Loperamide.
Hydrocodone Hydrocodone The metabolism of Hydrocodone can be decreased when combined with Loperamide.
Suvorexant Suvorexant The metabolism of Suvorexant can be decreased when combined with Loperamide.
Dulaglutide Injection Dulaglutide Injection The risk or severity of hypoglycemia can be increased when Loperamide is combined with Dulaglutide.
Edoxaban Edoxaban The serum concentration of Edoxaban can be increased when it is combined with Loperamide.
Olaparib Olaparib The metabolism of Olaparib can be decreased when combined with Loperamide.
Methamphetamine Methamphetamine The metabolism of Metamfetamine can be decreased when combined with Loperamide.
Tasimelteon Tasimelteon The metabolism of Tasimelteon can be decreased when combined with Loperamide.
Riociguat Riociguat The serum concentration of Riociguat can be increased when it is combined with Loperamide.
Lanreotide Injection Lanreotide Injection Loperamide may increase the bradycardic activities of Lanreotide.
Nintedanib Nintedanib The metabolism of Nintedanib can be decreased when combined with Loperamide.
Secukinumab Injection Secukinumab Injection The metabolism of Loperamide can be increased when combined with Secukinumab.
Risperidone Injection Risperidone Injection The risk or severity of QTc prolongation can be increased when Risperidone is combined with Loperamide.
Palbociclib Palbociclib The metabolism of Palbociclib can be decreased when combined with Loperamide.
Insulin Human Inhalation Insulin Human Inhalation The risk or severity of hypoglycemia can be increased when Loperamide is combined with Insulin human.
Lenvatinib Lenvatinib The serum concentration of Lenvatinib can be increased when it is combined with Loperamide.
Naloxegol Naloxegol The metabolism of Loperamide can be decreased when combined with Naloxegol.
Panobinostat Panobinostat The metabolism of Panobinostat can be decreased when combined with Loperamide.
Haloperidol Injection Haloperidol Injection The risk or severity of QTc prolongation can be increased when Haloperidol is combined with Loperamide.
Ivabradine Ivabradine Loperamide may increase the bradycardic activities of Ivabradine.
Amiloride Amiloride The risk or severity of hyperkalemia can be increased when Amiloride is combined with Loperamide.
Isavuconazonium Injection Isavuconazonium Injection The serum concentration of Loperamide can be increased when it is combined with Isavuconazonium.
Sonidegib Sonidegib The metabolism of Sonidegib can be decreased when combined with Loperamide.
Flibanserin Flibanserin The metabolism of Flibanserin can be decreased when combined with Loperamide.
Rolapitant Rolapitant The metabolism of Rolapitant can be decreased when combined with Loperamide.
Prednisolone Prednisolone The metabolism of Prednisolone can be decreased when combined with Loperamide.
Daclatasvir Daclatasvir The metabolism of Daclatasvir can be decreased when combined with Loperamide.
Brexpiprazole Brexpiprazole The metabolism of Brexpiprazole can be decreased when combined with Loperamide.
Ziprasidone Injection Ziprasidone Injection The risk or severity of QTc prolongation can be increased when Loperamide is combined with Ziprasidone.
Cariprazine Cariprazine The metabolism of Cariprazine can be decreased when combined with Loperamide.
Insulin Degludec (rDNA Origin) Injection Insulin Degludec (rDNA Origin) Injection The risk or severity of hypoglycemia can be increased when Loperamide is combined with Insulin degludec.
Cobimetinib Cobimetinib The metabolism of Cobimetinib can be decreased when combined with Loperamide.
Trabectedin Injection Trabectedin Injection The metabolism of Trabectedin can be decreased when combined with Loperamide.
Osimertinib Osimertinib The metabolism of Osimertinib can be decreased when combined with Loperamide.
Alectinib Alectinib The metabolism of Alectinib can be decreased when combined with Loperamide.
Ixazomib Ixazomib The metabolism of Ixazomib can be decreased when combined with Loperamide.
Rifapentine Rifapentine The metabolism of Loperamide can be increased when combined with Rifapentine.
Amphotericin B Liposomal Injection Amphotericin B Liposomal Injection Loperamide may decrease the nephrotoxic activities of Amphotericin B.
Dexamethasone Injection Dexamethasone Injection The metabolism of Loperamide can be decreased when combined with Dexamethasone.
Brivaracetam Injection Brivaracetam Injection The metabolism of Brivaracetam can be decreased when combined with Loperamide.
Venetoclax Venetoclax The metabolism of Venetoclax can be decreased when combined with Loperamide.
Cobicistat Cobicistat The serum concentration of Loperamide can be increased when it is combined with Cobicistat.
Midodrine Midodrine Midodrine may increase the bradycardic activities of Loperamide.
Selexipag Selexipag The serum concentration of Selexipag can be increased when it is combined with Loperamide.
Diphenhydramine Injection Diphenhydramine Injection The metabolism of Loperamide can be decreased when combined with Diphenhydramine.
Rucaparib Rucaparib The metabolism of Rucaparib can be decreased when combined with Loperamide.
Lixisenatide Injection Lixisenatide Injection The risk or severity of hypoglycemia can be increased when Loperamide is combined with Lixisenatide.
Ribociclib Ribociclib The metabolism of Ribociclib can be decreased when combined with Loperamide.
Brigatinib Brigatinib The metabolism of Brigatinib can be decreased when combined with Loperamide.
Doxepin (Insomnia) Doxepin (Insomnia) The metabolism of Loperamide can be decreased when combined with Doxepin.
Plecanatide Plecanatide The therapeutic efficacy of Plecanatide can be decreased when used in combination with Loperamide.
Deutetrabenazine Deutetrabenazine The risk or severity of QTc prolongation can be increased when Loperamide is combined with Deutetrabenazine.
Valbenazine Valbenazine The metabolism of Valbenazine can be decreased when combined with Loperamide.
Deflazacort Deflazacort The serum concentration of Deflazacort can be increased when it is combined with Loperamide.
Safinamide Safinamide The metabolism of Loperamide can be decreased when combined with Safinamide.
Midostaurin Midostaurin The metabolism of Loperamide can be decreased when combined with Midostaurin.
Neratinib Neratinib The serum concentration of Loperamide can be increased when it is combined with Neratinib.
Enasidenib Enasidenib The metabolism of Loperamide can be decreased when combined with Enasidenib.
Inotuzumab Ozogamicin Injection Inotuzumab Ozogamicin Injection The serum concentration of Inotuzumab ozogamicin can be increased when it is combined with Loperamide.
Aprepitant/Fosaprepitant Injection Aprepitant/Fosaprepitant Injection The metabolism of Fosaprepitant can be decreased when combined with Loperamide.
Copanlisib Injection Copanlisib Injection The metabolism of Copanlisib can be decreased when combined with Loperamide.
Delafloxacin Delafloxacin The risk or severity of QTc prolongation can be increased when Delafloxacin is combined with Loperamide.
Abemaciclib Abemaciclib The metabolism of Abemaciclib can be decreased when combined with Loperamide.
Betrixaban Betrixaban The serum concentration of Betrixaban can be increased when it is combined with Loperamide.
Acalabrutinib Acalabrutinib The metabolism of Acalabrutinib can be decreased when combined with Loperamide.
Letermovir Letermovir The metabolism of Loperamide can be decreased when combined with Letermovir.
Semaglutide Injection Semaglutide Injection The risk or severity of hypoglycemia can be increased when Loperamide is combined with Semaglutide.
Tetrabenazine Tetrabenazine The risk or severity of QTc prolongation can be increased when Loperamide is combined with Tetrabenazine.
Ertugliflozin Ertugliflozin The serum concentration of Ertugliflozin can be increased when it is combined with Loperamide.
Buprenorphine Injection Buprenorphine Injection The metabolism of Buprenorphine can be decreased when combined with Loperamide.
Apalutamide Apalutamide The serum concentration of Loperamide can be decreased when it is combined with Apalutamide.
Avatrombopag Avatrombopag The serum concentration of Avatrombopag can be increased when it is combined with Loperamide.
Baricitinib Baricitinib The metabolism of Baricitinib can be decreased when combined with Loperamide.
Lofexidine Lofexidine The risk or severity of QTc prolongation can be increased when Loperamide is combined with Lofexidine.
Eliglustat Eliglustat The metabolism of Eliglustat can be decreased when combined with Loperamide.
Encorafenib Encorafenib The risk or severity of QTc prolongation can be increased when Loperamide is combined with Encorafenib.
Binimetinib Binimetinib The serum concentration of Binimetinib can be increased when it is combined with Loperamide.
Ivosidenib Ivosidenib The metabolism of Ivosidenib can be decreased when combined with Loperamide.
Lusutrombopag Lusutrombopag The serum concentration of Lusutrombopag can be increased when it is combined with Loperamide.
Elagolix Elagolix The serum concentration of Elagolix can be increased when it is combined with Loperamide.
Tafenoquine Tafenoquine The metabolism of Tafenoquine can be decreased when combined with Loperamide.
Cannabidiol Cannabidiol The metabolism of Loperamide can be decreased when combined with Cannabidiol.
Dacomitinib Dacomitinib The metabolism of Dacomitinib can be decreased when combined with Loperamide.
Duvelisib Duvelisib The metabolism of Duvelisib can be decreased when combined with Loperamide.
Omadacycline Omadacycline The serum concentration of Omadacycline can be increased when it is combined with Loperamide.
Sarecycline Sarecycline The serum concentration of Loperamide can be increased when it is combined with Sarecycline.
Stiripentol Stiripentol The metabolism of Loperamide can be decreased when combined with Stiripentol.
Talazoparib Talazoparib The serum concentration of Talazoparib can be increased when it is combined with Loperamide.
Gilteritinib Gilteritinib The metabolism of Gilteritinib can be decreased when combined with Loperamide.
Glasdegib Glasdegib The risk or severity of QTc prolongation can be increased when Loperamide is combined with Glasdegib.
Lorlatinib Lorlatinib The metabolism of Lorlatinib can be decreased when combined with Loperamide.
Larotrectinib Larotrectinib The serum concentration of Larotrectinib can be increased when it is combined with Loperamide.
Paclitaxel (with albumin) Injection Paclitaxel (with albumin) Injection The metabolism of Paclitaxel can be decreased when combined with Loperamide.
Rifamycin Rifamycin The serum concentration of Rifamycin can be increased when it is combined with Loperamide.
Prucalopride Prucalopride The metabolism of Prucalopride can be decreased when combined with Loperamide.
Magnesium Citrate Magnesium Citrate The risk or severity of hypotension can be increased when Loperamide is combined with Magnesium citrate.
Emapalumab-lzsg Injection Emapalumab-lzsg Injection The metabolism of Loperamide can be increased when combined with Emapalumab.
Siponimod Siponimod The risk or severity of adverse effects can be increased when Loperamide is combined with Siponimod.
Erdafitinib Erdafitinib The serum concentration of Loperamide can be increased when it is combined with Erdafitinib.
Alpelisib Alpelisib The metabolism of Alpelisib can be decreased when combined with Loperamide.
Polatuzumab vedotin-piiq Injection Polatuzumab vedotin-piiq Injection The risk or severity of adverse effects can be increased when Loperamide is combined with Polatuzumab vedotin.
Darolutamide Darolutamide The serum concentration of Darolutamide can be increased when it is combined with Loperamide.
Triclabendazole Triclabendazole The metabolism of Loperamide can be decreased when combined with Triclabendazole.
Entrectinib Entrectinib The metabolism of Entrectinib can be decreased when combined with Loperamide.
Pexidartinib Pexidartinib The metabolism of Pexidartinib can be decreased when combined with Loperamide.
Upadacitinib Upadacitinib The metabolism of Upadacitinib can be decreased when combined with Loperamide.
Istradefylline Istradefylline The serum concentration of Loperamide can be increased when it is combined with Istradefylline.
Pitolisant Pitolisant The serum concentration of Loperamide can be decreased when it is combined with Pitolisant.
Pretomanid Pretomanid The serum concentration of Pretomanid can be increased when it is combined with Loperamide.
Fedratinib Fedratinib The serum concentration of Fedratinib can be increased when it is combined with Loperamide.
Lefamulin Lefamulin Loperamide may increase the QTc-prolonging activities of Lefamulin.
Phenytoin Injection Phenytoin Injection The metabolism of Loperamide can be decreased when combined with Phenytoin.
Fosphenytoin Injection Fosphenytoin Injection The metabolism of Fosphenytoin can be decreased when combined with Loperamide.
Enfortumab vedotin-ejfv Injection Enfortumab vedotin-ejfv Injection The serum concentration of Enfortumab vedotin can be increased when it is combined with Loperamide.
Zanubrutinib Zanubrutinib The metabolism of Zanubrutinib can be decreased when combined with Loperamide.
Voxelotor Voxelotor The serum concentration of Voxelotor can be increased when it is combined with Loperamide.
Lumateperone Lumateperone The serum concentration of Lumateperone can be increased when it is combined with Loperamide.
Lasmiditan Lasmiditan The serum concentration of Loperamide can be increased when it is combined with Lasmiditan.
Ubrogepant Ubrogepant The serum concentration of Ubrogepant can be increased when it is combined with Loperamide.
Calcium Acetate Calcium Acetate The therapeutic efficacy of Loperamide can be decreased when used in combination with Calcium acetate.
Tazemetostat Tazemetostat The metabolism of Tazemetostat can be decreased when combined with Loperamide.
Cenobamate Cenobamate The serum concentration of Cenobamate can be decreased when it is combined with Loperamide.
Pemigatinib Pemigatinib The metabolism of Pemigatinib can be decreased when combined with Loperamide.
Ozanimod Ozanimod The metabolism of Ozanimod can be decreased when combined with Loperamide.
Selumetinib Selumetinib The serum concentration of Selumetinib can be increased when it is combined with Loperamide.
Rimegepant Rimegepant The metabolism of Rimegepant can be decreased when combined with Loperamide.
Tucatinib Tucatinib Loperamide may decrease the excretion rate of Tucatinib which could result in a higher serum level.
Remdesivir Injection Remdesivir Injection The serum concentration of Remdesivir can be increased when it is combined with Loperamide.
Ripretinib Ripretinib The serum concentration of Loperamide can be increased when it is combined with Ripretinib.
Selpercatinib Selpercatinib The serum concentration of Loperamide can be increased when it is combined with Selpercatinib.
Lemborexant Lemborexant The serum concentration of Loperamide can be decreased when it is combined with Lemborexant.
Fenfluramine Fenfluramine The metabolism of Loperamide can be decreased when combined with Fenfluramine.
Fostemsavir Fostemsavir The risk or severity of QTc prolongation can be increased when Fostemsavir is combined with Loperamide.
Lurbinectedin Injection Lurbinectedin Injection The serum concentration of Lurbinectedin can be increased when it is combined with Loperamide.
Octreotide Octreotide The serum concentration of the active metabolites of Loperamide can be increased when Loperamide is used in combination with Octreotide.
Belantamab Mafodotin-blmf Injection Belantamab Mafodotin-blmf Injection The serum concentration of Belantamab mafodotin can be increased when it is combined with Loperamide.
Pralsetinib Pralsetinib The serum concentration of Loperamide can be increased when it is combined with Pralsetinib.
Opicapone Opicapone The metabolism of Loperamide can be decreased when combined with Opicapone.
Satralizumab-mwge Injection Satralizumab-mwge Injection The serum concentration of Loperamide can be decreased when it is combined with Satralizumab.
Relugolix Relugolix The risk or severity of QTc prolongation can be increased when Relugolix is combined with Loperamide.
Progestin-Only (drospirenone) Oral Contraceptives Progestin-Only (drospirenone) Oral Contraceptives The metabolism of Drospirenone can be decreased when combined with Loperamide.
Theophylline Theophylline The metabolism of Theophylline can be decreased when combined with Loperamide.
Fenoprofen Fenoprofen The risk or severity of hyperkalemia can be increased when Fenoprofen is combined with Loperamide.
Indomethacin Indomethacin The risk or severity of hyperkalemia can be increased when Indomethacin is combined with Loperamide.
Mefenamic Acid Mefenamic Acid The metabolism of Loperamide can be decreased when combined with Mefenamic acid.
Naproxen Naproxen The metabolism of Loperamide can be decreased when combined with Naproxen.
Tolmetin Tolmetin The risk or severity of hyperkalemia can be increased when Tolmetin is combined with Loperamide.
Sulindac Sulindac The risk or severity of hyperkalemia can be increased when Sulindac is combined with Loperamide.
Trazodone Trazodone The risk or severity of QTc prolongation can be increased when Trazodone is combined with Loperamide.
Hydroxyurea Hydroxyurea The metabolism of Loperamide can be decreased when combined with Hydroxyurea.
Phenobarbital Phenobarbital The metabolism of Loperamide can be increased when combined with Phenobarbital.
Methotrexate Injection Methotrexate Injection The metabolism of Methotrexate can be decreased when combined with Loperamide.
Primidone Primidone The metabolism of Loperamide can be increased when combined with Primidone.
Methsuximide Methsuximide Methsuximide may increase the arrhythmogenic activities of Loperamide.
Chlorpromazine Chlorpromazine The metabolism of Chlorpromazine can be decreased when combined with Loperamide.
Lorazepam Lorazepam The metabolism of Lorazepam can be decreased when combined with Loperamide.
Phenoxybenzamine Phenoxybenzamine The risk or severity of hypotension can be increased when Phenoxybenzamine is combined with Loperamide.
Amantadine Amantadine The risk or severity of QTc prolongation can be increased when Amantadine is combined with Loperamide.
Codeine Codeine The metabolism of Loperamide can be decreased when combined with Codeine.
Bromocriptine Bromocriptine The risk or severity of hypotension can be increased when Bromocriptine is combined with Loperamide.
Tranylcypromine Tranylcypromine The metabolism of Loperamide can be decreased when combined with Tranylcypromine.
Phenelzine Phenelzine The metabolism of Loperamide can be decreased when combined with Phenelzine.
Prochlorperazine Prochlorperazine The metabolism of Prochlorperazine can be decreased when combined with Loperamide.
Thioridazine Thioridazine The metabolism of Loperamide can be decreased when combined with Thioridazine.
Trifluoperazine Trifluoperazine The risk or severity of hypotension can be increased when Trifluoperazine is combined with Loperamide.
Dapsone Dapsone The metabolism of Loperamide can be decreased when combined with Dapsone.
Sulfadiazine Sulfadiazine The metabolism of Loperamide can be decreased when combined with Sulfadiazine.
Oxycodone Oxycodone The metabolism of Loperamide can be decreased when combined with Oxycodone.
Methadone Methadone The metabolism of Loperamide can be decreased when combined with Methadone.
Oxybutynin Oxybutynin The metabolism of Loperamide can be decreased when combined with Oxybutynin.
Benztropine Benztropine The risk or severity of QTc prolongation can be increased when Benzatropine is combined with Loperamide.
Maprotiline Maprotiline The risk or severity of QTc prolongation can be increased when Maprotiline is combined with Loperamide.
Ibuprofen Ibuprofen The metabolism of Ibuprofen can be decreased when combined with Loperamide.
Orphenadrine Orphenadrine The metabolism of Loperamide can be decreased when combined with Orphenadrine.
Perphenazine Perphenazine The metabolism of Loperamide can be decreased when combined with Perphenazine.
Fluphenazine Fluphenazine The metabolism of Loperamide can be decreased when combined with Fluphenazine.
Phentermine Phentermine The metabolism of Phentermine can be decreased when combined with Loperamide.
Amoxapine Amoxapine The metabolism of Loperamide can be decreased when combined with Amoxapine.
Sulfasalazine Sulfasalazine The risk or severity of hyperkalemia can be increased when Sulfasalazine is combined with Loperamide.
Hydrocortisone Hydrocortisone The metabolism of Loperamide can be decreased when combined with Hydrocortisone.
Doxorubicin Doxorubicin The metabolism of Loperamide can be decreased when combined with Doxorubicin.
Dactinomycin Dactinomycin The serum concentration of Dactinomycin can be increased when it is combined with Loperamide.
Carbamazepine Carbamazepine The metabolism of Carbamazepine can be decreased when combined with Loperamide.
Methyldopa Methyldopa Loperamide may increase the bradycardic activities of Methyldopa.
Clonidine Clonidine Clonidine may increase the atrioventricular blocking (AV block) activities of Loperamide.
Prazosin Prazosin The risk or severity of hypotension can be increased when Prazosin is combined with Loperamide.
Cimetidine Cimetidine The serum concentration of Loperamide can be increased when it is combined with Cimetidine.
Warfarin Warfarin The serum concentration of Warfarin can be increased when it is combined with Loperamide.
Promethazine Promethazine The metabolism of Loperamide can be decreased when combined with Promethazine.
Meclofenamate Meclofenamate The risk or severity of hyperkalemia can be increased when Loperamide is combined with Meclofenamic acid.
Nitrofurantoin Nitrofurantoin The risk or severity of hyperkalemia can be increased when Nitrofurantoin is combined with Loperamide.
Griseofulvin Griseofulvin The metabolism of Loperamide can be increased when combined with Griseofulvin.
Digoxin Digoxin Loperamide may increase the arrhythmogenic activities of Digoxin.
Loxapine Loxapine The serum concentration of Loperamide can be increased when it is combined with Loxapine.
Chloroquine Chloroquine The metabolism of Chloroquine can be decreased when combined with Loperamide.
Quinine Quinine The metabolism of Quinine can be decreased when combined with Loperamide.
Ethosuximide Ethosuximide Ethosuximide may increase the arrhythmogenic activities of Loperamide.
Triamterene Triamterene The risk or severity of hyperkalemia can be increased when Triamterene is combined with Loperamide.
Lactulose Lactulose The therapeutic efficacy of Lactulose can be decreased when used in combination with Loperamide.
Sulfinpyrazone Sulfinpyrazone The metabolism of Loperamide can be decreased when combined with Sulfinpyrazone.
Isosorbide Isosorbide Loperamide may increase the vasodilatory activities of Isosorbide.
Secobarbital Secobarbital The metabolism of Loperamide can be increased when combined with Secobarbital.
Desipramine Desipramine The metabolism of Desipramine can be decreased when combined with Loperamide.
Amitriptyline Amitriptyline The metabolism of Loperamide can be decreased when combined with Amitriptyline.
Imipramine Imipramine The metabolism of Imipramine can be decreased when combined with Loperamide.
Probenecid Probenecid The metabolism of Loperamide can be increased when combined with Probenecid.
Quinidine Quinidine Loperamide may increase the arrhythmogenic activities of Quinidine.
Procainamide Procainamide Loperamide may increase the arrhythmogenic activities of Procainamide.
Rifampin Rifampin The metabolism of Loperamide can be increased when combined with Rifampicin.
Disopyramide Disopyramide Loperamide may increase the arrhythmogenic activities of Disopyramide.
Valproic Acid Valproic Acid The risk or severity of QTc prolongation can be increased when Loperamide is combined with Valproic acid.
Tamoxifen Tamoxifen The metabolism of Loperamide can be decreased when combined with Tamoxifen.
Butabarbital Butabarbital The metabolism of Loperamide can be increased when combined with Butabarbital.
Levothyroxine Levothyroxine The metabolism of Loperamide can be decreased when combined with Levothyroxine.
Methimazole Methimazole The metabolism of Loperamide can be decreased when combined with Methimazole.
Chlorpropamide Chlorpropamide The risk or severity of hypoglycemia can be increased when Loperamide is combined with Chlorpropamide.
Tolbutamide Tolbutamide The metabolism of Tolbutamide can be decreased when combined with Loperamide.
Tolazamide Tolazamide The risk or severity of hypoglycemia can be increased when Loperamide is combined with Tolazamide.
Dextromethorphan Dextromethorphan The metabolism of Loperamide can be decreased when combined with Dextromethorphan.
Niacin Niacin The metabolism of Loperamide can be decreased when combined with Niacin.
Doxylamine Doxylamine The risk or severity of QTc prolongation can be increased when Doxylamine is combined with Loperamide.
Cyproheptadine Cyproheptadine The risk or severity of QTc prolongation can be increased when Cyproheptadine is combined with Loperamide.
Clemastine Clemastine The risk or severity of QTc prolongation can be increased when Loperamide is combined with Clemastine.
Chlorpheniramine Chlorpheniramine The metabolism of Loperamide can be decreased when combined with Chlorpheniramine.
Brompheniramine Brompheniramine The risk or severity of QTc prolongation can be increased when Dexbrompheniramine is combined with Loperamide.
Meclizine Meclizine The metabolism of Loperamide can be decreased when combined with Meclizine.
Hydrochlorothiazide Hydrochlorothiazide The risk or severity of QTc prolongation can be increased when Hydrochlorothiazide is combined with Loperamide.
Dantrolene Dantrolene The risk or severity of hyperkalemia can be increased when Dantrolene is combined with Loperamide.
Chlorzoxazone Chlorzoxazone The metabolism of Loperamide can be decreased when combined with Chlorzoxazone.
Disulfiram Disulfiram The risk or severity of QTc prolongation can be increased when Disulfiram is combined with Loperamide.
Propranolol (Cardiovascular) Propranolol (Cardiovascular) The risk or severity of bradycardia can be increased when Propranolol is combined with Loperamide.
Nortriptyline Nortriptyline The metabolism of Loperamide can be decreased when combined with Nortriptyline.
Spironolactone Spironolactone The metabolism of Loperamide can be decreased when combined with Spironolactone.
Amphotericin B Injection Amphotericin B Injection Loperamide may decrease the nephrotoxic activities of Amphotericin B.
Nadolol Nadolol The risk or severity of bradycardia can be increased when Loperamide is combined with Nadolol.
Oxytocin Injection Oxytocin Injection The risk or severity of QTc prolongation can be increased when Oxytocin is combined with Loperamide.
Clomiphene Clomiphene The serum concentration of Clomifene can be increased when it is combined with Loperamide.
Papaverine Papaverine The risk or severity of QTc prolongation can be increased when Loperamide is combined with Papaverine.
Fluorouracil Injection Fluorouracil Injection The metabolism of Loperamide can be decreased when combined with Fluorouracil.
Colchicine Colchicine The metabolism of Colchicine can be decreased when combined with Loperamide.
Cephalexin Cephalexin The metabolism of Cephalexin can be decreased when combined with Loperamide.
Ketoconazole Ketoconazole The metabolism of Ketoconazole can be decreased when combined with Loperamide.
Thiotepa Injection Thiotepa Injection The metabolism of Loperamide can be decreased when combined with Thiotepa.
Vincristine Injection Vincristine Injection The metabolism of Vincristine can be decreased when combined with Loperamide.
Captopril Captopril The risk or severity of hyperkalemia can be increased when Loperamide is combined with Captopril.
Vinblastine Vinblastine The metabolism of Loperamide can be decreased when combined with Vinblastine.
Metoprolol Metoprolol The metabolism of Metoprolol can be decreased when combined with Loperamide.
Hydroxyzine Hydroxyzine The risk or severity of QTc prolongation can be increased when Hydroxyzine is combined with Loperamide.
Thiothixene Thiothixene The risk or severity of QTc prolongation can be increased when Thiothixene is combined with Loperamide.
Aspirin Aspirin The risk or severity of hyperkalemia can be increased when Loperamide is combined with Acetylsalicylic acid.
Salsalate Salsalate The risk or severity of hyperkalemia can be increased when Loperamide is combined with Salsalate.
Alprazolam Alprazolam The metabolism of Alprazolam can be decreased when combined with Loperamide.
Hyoscyamine Hyoscyamine Hyoscyamine may increase the arrhythmogenic activities of Loperamide.
Trimethoprim Trimethoprim The metabolism of Loperamide can be decreased when combined with Trimethoprim.
Diltiazem Diltiazem Diltiazem may increase the arrhythmogenic activities of Loperamide.
Nifedipine Nifedipine Loperamide may increase the arrhythmogenic activities of Nifedipine.
Timolol Timolol The risk or severity of adverse effects can be increased when Loperamide is combined with Timolol.
Verapamil Verapamil Verapamil may increase the arrhythmogenic activities of Loperamide.
Atenolol Atenolol The risk or severity of bradycardia can be increased when Loperamide is combined with Atenolol.
Pindolol Pindolol The risk or severity of bradycardia can be increased when Loperamide is combined with Pindolol.
Cisplatin Injection Cisplatin Injection The metabolism of Loperamide can be decreased when combined with Cisplatin.
Diflunisal Diflunisal The risk or severity of hyperkalemia can be increased when Loperamide is combined with Diflunisal.
Piroxicam Piroxicam The metabolism of Loperamide can be decreased when combined with Piroxicam.
Etoposide Etoposide The metabolism of Loperamide can be decreased when combined with Etoposide.
Glyburide Glyburide The risk or severity of hypoglycemia can be increased when Loperamide is combined with Glyburide.
Glipizide Glipizide The risk or severity of hypoglycemia can be increased when Loperamide is combined with Glipizide.
Indapamide Indapamide The risk or severity of QTc prolongation can be increased when Indapamide is combined with Loperamide.
Nafcillin Injection Nafcillin Injection The therapeutic efficacy of Loperamide can be decreased when used in combination with Nafcillin.
Pentamidine Injection Pentamidine Injection The risk or severity of QTc prolongation can be increased when Pentamidine is combined with Loperamide.
Labetalol Labetalol The risk or severity of bradycardia can be increased when Labetalol is combined with Loperamide.
Leuprolide Injection Leuprolide Injection The risk or severity of QTc prolongation can be increased when Leuprolide is combined with Loperamide.
Gemfibrozil Gemfibrozil The metabolism of Loperamide can be decreased when combined with Gemfibrozil.
Ketoprofen Ketoprofen The risk or severity of hyperkalemia can be increased when Loperamide is combined with Ketoprofen.
Pimozide Pimozide The metabolism of Pimozide can be decreased when combined with Loperamide.
Enalapril Enalapril The risk or severity of hyperkalemia can be increased when Enalapril is combined with Loperamide.
Flurbiprofen Flurbiprofen The risk or severity of hyperkalemia can be increased when Flurbiprofen is combined with Loperamide.
Amiodarone Amiodarone The risk or severity of adverse effects can be increased when Loperamide is combined with Amiodarone.
Buspirone Buspirone The metabolism of Loperamide can be decreased when combined with Buspirone.
Lovastatin Lovastatin The serum concentration of Lovastatin can be increased when it is combined with Loperamide.
Ciprofloxacin Ciprofloxacin The risk or severity of QTc prolongation can be increased when Ciprofloxacin is combined with Loperamide.
Mesalamine Mesalamine The risk or severity of hyperkalemia can be increased when Mesalazine is combined with Loperamide.
Diclofenac Diclofenac The metabolism of Loperamide can be decreased when combined with Diclofenac.
Fluoxetine Fluoxetine The serum concentration of Fluoxetine can be increased when it is combined with Loperamide.
Nimodipine Nimodipine Nimodipine may increase the arrhythmogenic activities of Loperamide.
Clozapine Clozapine The metabolism of Clozapine can be decreased when combined with Loperamide.
Idarubicin Idarubicin The metabolism of Idarubicin can be decreased when combined with Loperamide.
Ofloxacin Ofloxacin The risk or severity of QTc prolongation can be increased when Loperamide is combined with Ofloxacin.
Clarithromycin Clarithromycin The serum concentration of Clarithromycin can be increased when it is combined with Loperamide.
Benazepril Benazepril The risk or severity of hyperkalemia can be increased when Benazepril is combined with Loperamide.
Etodolac Etodolac The risk or severity of hyperkalemia can be increased when Etodolac is combined with Loperamide.
Felodipine Felodipine Loperamide may increase the arrhythmogenic activities of Felodipine.
Fosinopril Fosinopril The risk or severity of hyperkalemia can be increased when Fosinopril is combined with Loperamide.
Nabumetone Nabumetone The risk or severity of hyperkalemia can be increased when Nabumetone is combined with Loperamide.
Pravastatin Pravastatin The serum concentration of Loperamide can be increased when it is combined with Pravastatin.
Quinapril Quinapril The risk or severity of hyperkalemia can be increased when Loperamide is combined with Quinapril.
Ramipril Ramipril The risk or severity of hyperkalemia can be increased when Ramipril is combined with Loperamide.
Simvastatin Simvastatin The metabolism of Loperamide can be decreased when combined with Simvastatin.
Amlodipine Amlodipine The metabolism of Amlodipine can be decreased when combined with Loperamide.
Teniposide Injection Teniposide Injection The metabolism of Teniposide can be decreased when combined with Loperamide.
Itraconazole Itraconazole The metabolism of Itraconazole can be decreased when combined with Loperamide.
Lisinopril Lisinopril The risk or severity of hyperkalemia can be increased when Lisinopril is combined with Loperamide.
Oxaprozin Oxaprozin The risk or severity of hyperkalemia can be increased when Loperamide is combined with Oxaprozin.
Rifabutin Rifabutin The metabolism of Loperamide can be increased when combined with Rifabutin.
Sotalol Sotalol The risk or severity of bradycardia can be increased when Loperamide is combined with Sotalol.
Bisoprolol Bisoprolol The therapeutic efficacy of Loperamide can be increased when used in combination with Bisoprolol.
Zolpidem Zolpidem The metabolism of Zolpidem can be decreased when combined with Loperamide.
Doxazosin Doxazosin The metabolism of Doxazosin can be decreased when combined with Loperamide.
Terazosin Terazosin The risk or severity of hypotension can be increased when Terazosin is combined with Loperamide.
Isradipine Isradipine Isradipine may increase the arrhythmogenic activities of Loperamide.
Omeprazole Omeprazole The metabolism of Loperamide can be decreased when combined with Omeprazole.
Cisapride Cisapride The risk or severity of QTc prolongation can be increased when Loperamide is combined with Cisapride.
Fluvastatin Fluvastatin The metabolism of Loperamide can be increased when combined with Fluvastatin.
Venlafaxine Venlafaxine The metabolism of Venlafaxine can be decreased when combined with Loperamide.
Famciclovir Famciclovir The metabolism of Famciclovir can be decreased when combined with Loperamide.
Fluvoxamine Fluvoxamine The metabolism of Fluvoxamine can be decreased when combined with Loperamide.
Nefazodone Nefazodone The risk or severity of hypotension can be increased when Nefazodone is combined with Loperamide.
Lamotrigine Lamotrigine Lamotrigine may increase the arrhythmogenic activities of Loperamide.
Losartan Losartan Losartan may increase the arrhythmogenic activities of Loperamide.
Tramadol Tramadol The metabolism of Tramadol can be decreased when combined with Loperamide.
Vinorelbine Injection Vinorelbine Injection The metabolism of Loperamide can be decreased when combined with Vinorelbine.
Moexipril Moexipril The risk or severity of QTc prolongation can be increased when Moexipril is combined with Loperamide.
Lansoprazole Lansoprazole The metabolism of Loperamide can be decreased when combined with Lansoprazole.
Ifosfamide Injection Ifosfamide Injection The metabolism of Ifosfamide can be decreased when combined with Loperamide.
Nicardipine Nicardipine The metabolism of Nicardipine can be decreased when combined with Loperamide.
Bupropion Bupropion The metabolism of Loperamide can be decreased when combined with Bupropion.
Ticlopidine Ticlopidine The metabolism of Loperamide can be decreased when combined with Ticlopidine.
Saquinavir Saquinavir The metabolism of Loperamide can be decreased when combined with Saquinavir.
Metformin Metformin The risk or severity of hypoglycemia can be increased when Loperamide is combined with Metformin.
Dalteparin Injection Dalteparin Injection The risk or severity of hyperkalemia can be increased when Loperamide is combined with Dalteparin.
Nisoldipine Nisoldipine Loperamide may increase the arrhythmogenic activities of Nisoldipine.
Acarbose Acarbose The risk or severity of hypoglycemia can be increased when Loperamide is combined with Acarbose.
Glimepiride Glimepiride Loperamide may increase the arrhythmogenic activities of Glimepiride.
Anastrozole Anastrozole The metabolism of Anastrozole can be decreased when combined with Loperamide.
Gemcitabine Injection Gemcitabine Injection The serum concentration of Gemcitabine can be increased when it is combined with Loperamide.
Ritonavir Ritonavir The serum concentration of Loperamide can be increased when it is combined with Ritonavir.
Docetaxel Injection Docetaxel Injection The metabolism of Docetaxel can be decreased when combined with Loperamide.
Clomipramine Clomipramine The metabolism of Clomipramine can be decreased when combined with Loperamide.
Zafirlukast Zafirlukast The metabolism of Loperamide can be decreased when combined with Zafirlukast.
Mirtazapine Mirtazapine The risk or severity of QTc prolongation can be increased when Mirtazapine is combined with Loperamide.
Trandolapril Trandolapril The risk or severity of hyperkalemia can be increased when Trandolapril is combined with Loperamide.
Valsartan Valsartan The risk or severity of hyperkalemia can be increased when Valsartan is combined with Loperamide.
Insulin Lispro Injection Insulin Lispro Injection The risk or severity of hypoglycemia can be increased when Loperamide is combined with Insulin lispro.
Donepezil Donepezil The metabolism of Donepezil can be decreased when combined with Loperamide.
Nelfinavir Nelfinavir The metabolism of Loperamide can be decreased when combined with Nelfinavir.
Fexofenadine Fexofenadine The serum concentration of Fexofenadine can be increased when it is combined with Loperamide.
Azithromycin Azithromycin The metabolism of Azithromycin can be decreased when combined with Loperamide.
Loratadine Loratadine The metabolism of Loperamide can be decreased when combined with Loratadine.
Carvedilol Carvedilol The risk or severity of bradycardia can be increased when Carvedilol is combined with Loperamide.
Nilutamide Nilutamide The metabolism of Loperamide can be decreased when combined with Nilutamide.
Selegiline Selegiline The metabolism of Selegiline can be decreased when combined with Loperamide.
Bicalutamide Bicalutamide The metabolism of Loperamide can be decreased when combined with Bicalutamide.
Sertraline Sertraline The metabolism of Loperamide can be decreased when combined with Sertraline.
Propafenone Propafenone The risk or severity of bradycardia can be increased when Propafenone is combined with Loperamide.
Raloxifene Raloxifene The metabolism of Loperamide can be decreased when combined with Raloxifene.
Irbesartan Irbesartan The metabolism of Loperamide can be decreased when combined with Irbesartan.
Tamsulosin Tamsulosin The risk or severity of hypotension can be increased when Tamsulosin is combined with Loperamide.
Quetiapine Quetiapine The serum concentration of Quetiapine can be increased when it is combined with Loperamide.
Cetirizine Cetirizine The risk or severity of QTc prolongation can be increased when Cetirizine is combined with Loperamide.
Paroxetine Paroxetine The metabolism of Loperamide can be decreased when combined with Paroxetine.
Citalopram Citalopram The risk or severity of QTc prolongation can be increased when Loperamide is combined with Citalopram.
Efavirenz Efavirenz The serum concentration of Loperamide can be decreased when it is combined with Efavirenz.
Sildenafil Sildenafil The metabolism of Sildenafil can be decreased when combined with Loperamide.
Pioglitazone Pioglitazone The metabolism of Loperamide can be decreased when combined with Pioglitazone.
Celecoxib Celecoxib The metabolism of Celecoxib can be decreased when combined with Loperamide.
Rosiglitazone Rosiglitazone The metabolism of Loperamide can be decreased when combined with Rosiglitazone.
Tolterodine Tolterodine The serum concentration of Tolterodine can be increased when it is combined with Loperamide.
Balsalazide Balsalazide The risk or severity of hyperkalemia can be increased when Loperamide is combined with Balsalazide.
Nateglinide Nateglinide The risk or severity of hypoglycemia can be increased when Nateglinide is combined with Loperamide.
Galantamine Galantamine The risk or severity of QTc prolongation can be increased when Galantamine is combined with Loperamide.
Rabeprazole Rabeprazole The metabolism of Loperamide can be decreased when combined with Rabeprazole.
Terbinafine Terbinafine The metabolism of Terbinafine can be decreased when combined with Loperamide.

Content provided by: AHFS® Patient Medication Information™. © Copyright, 2021. The American Society of Health-System Pharmacists